This Site makes extensive use of Adobe Acrobat for its Documents - click on the image above to download the Adobe Acrobat Reader.
Go to the UL Lafayette Homepage


HEPATITIS B VACCINE
PATIENT INFORMATION


HEPATITIS B:
Is a serious viral infection primarily affecting the liver. It is primarily transmitted by blood and blood products, but has also been found in tears, saliva, breast milk, urine, semen and vaginal secretions. Can cause loss of work due to illness, is a chronic illness and rarely can cause death. It has no cure.


HEPATITIS B VACCINE:

Is recommended to persons who are at increased risk of being infected with Hepatitis B virus, to prevent infection from the Hepatitis B virus, and is given according to the following schedule:

1st dose at elected date.
2nd dose one (1) month later.
3rd dose four (4) to six (6) months after the 1st dose.


CONTRAINDICATIONS INCLUDE ANY HISTORY OF:

    •Allergy to yeast
    •Immunocompromised state
    •Dialysis
 

 •Coagulation disorder or multiple sclerosis



RISKS:

 

•May cause local soreness, swelling and redness where the shot was given, which may last one to two days.

  •May also cause fever, headache and dizziness.
 

•May less often cause flu like symptoms, tingling, upper respiratory infection, nausea, loss of appetite, abdominal pain/cramps, vomiting, constipation, diarrhea, enlarged lymph nodes, rash, itching, sleep disturbances and acute or delayed hypersensitivity reaction.



If you have a serious or unusual problem after getting the Hepatitis B vaccine, call your physician or go to a medical facility promptly. If you have a reaction to the vaccine, write down exactly what happened and report to a nurse at UL Lafayette Student Health Service by calling (337)482-5464.

 

 

© Copyright 2001 by the University of Louisiana at Lafayette.
Student Health Services, P.O. Box 43692, Lafayette, LA, 70504-3692
Phn: 337/482-5464 ·Fax: 337/482-6428 · Email: shs@louisiana.edu
Website designed by Tony Lightfoot